Investigating the Relationship Between Midazolam Serum Concentrations and Paediatric Delirium in Critically Ill
Sabrina Marongiu1,2, Mathieu S Bolhuis1, Daan J Touw1,2
1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Insights
Paediatric delirium (PD) in critically ill children may be linked to sudden drops in midazolam serum concentration. This pilot study suggests that reduced midazolam levels, not just dose, might trigger PD, warranting further research.
Area of Science:
- Pediatric Intensive Care
- Pharmacology
- Neuroscience
Background:
- Intravenous midazolam is a common sedative for critically ill children.
- Paediatric delirium (PD) is a potential complication in these patients.
- The relationship between midazolam levels and PD is not fully understood.
Purpose of the Study:
- To investigate the association between midazolam serum concentration and the development of new paediatric delirium (PD) in critically ill children.
- To explore if changes in midazolam levels correlate with PD onset.
Main Methods:
- Prospective observational pilot study conducted in a Paediatric Intensive Care Unit (PICU).
- Included 28 critically ill children receiving continuous midazolam.
- Monitored midazolam serum concentrations and used the Sophia Observation withdrawal Symptoms-Paediatric Delirium (SOS-PD) score to assess for PD.
Main Results:
- Twenty-five percent (7/28) of children developed new PD, often after midazolam dose reduction.
- Patients with PD had a lower median midazolam concentration on the day of PD detection compared to the previous day.
- Similar trends were observed for active midazolam metabolites.
Conclusions:
- A sudden and significant reduction in midazolam concentration may be associated with the development of PD in critically ill children.
- Further research in larger cohorts is needed to confirm these findings and understand the underlying mechanisms.
Objectives:
Intravenous midazolam is widely used for sedation in critically ill children. Sometimes, these children develop a paediatric delirium (PD). Our aim was to determine the relationship between midazolam serum concentration and the development of new PD in critically ill children.
Design:
Prospective observational pilot study.
Setting:
Paediatric Intensive Care Unit (PICU), Groningen, the Netherlands.
Patients:
All children admitted to the PICU from October-December 2019 who received continuous midazolam administration.
Interventions:
None.
Measurements And Main Results:
Twenty-five percent (n = 7) of the included patients (n = 28) developed new PD. In most patients, PD occurred following midazolam dose reduction. The median cumulative midazolam dose was higher in patients who developed PD compared to those without PD. We analysed 104 blood samples to determine the midazolam concentrations. To determine whether patients had PD, the Sophia Observation withdrawal Symptoms-Paediatric Delirium (SOS-PD) score was used. Patients suffering PD (n = 7) had a lower median midazolam concentration on that day compared with the day prior to PD detection. Analysis of the active metabolites, 1-hydroxymidazolam and 1-hydroxymidazolam glucuronide, showed similar results.
Conclusions:
PD may be linked to a sudden and significant reduction in the midazolam concentration in critically ill children. Further investigation in larger patient populations is necessary to validate our findings.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Stages of General Anesthesia
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Drug Response: Overview
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Inhalational Anesthetics: Overview


